Aetiologies and outcomes of pediatric-onset bronchiectasis in adults: data from the EMBARC registry
<bold>Background:</bold> Pediatric and adult bronchiectasis have different clinical profiles but data on long-term follow-up of children with bronchiectasis are scarce. We compared the aetiologies and outcomes of adults with pediatric-onset (paed-BE) bronchiectasis compared with adult-onset (adult-BE) bronchiectasis in the EMBARC registry. <bold>Methods:</bold> Patients ≤47 years old were included. People with paed-BE bronchiectasis were defined as adults with a bronchiectasis diagnosis made ≥20 years ago, and adult-BE as diagnosis made <20 years ago. We compared data on demography, aetiology and severity measures between paed-BE and adult-BE. <bold>Results:</bold> 663 adults with paed-BE and 1237 with adult- BE were included. Compared to adult-BE, Paed-BE were younger (median (IQR) 28(22-36) vs. 37(32-41) years) and more likely to be never smokers (85.7% vs. 66.6%, p<.001). Rhinosinusitis and nasal polyps were more common in paed-BE than in adult-BE (41.6% vs. 27.6% and 18.8% vs. 10.3%, respectively, p<.001) while asthma was more common in adult- BE (36.4% vs. 26.8%). Paed-BE were more likely to have an aetiology of PCD: 29.4% vs. 6.8% (p<.001), and less like to have an idiopathic aetiology (27.5% vs. 37.2%, p<.001). Patients with paed-BE had lower lung function and worse severity than adult- BE: median FEV<sub>1</sub>% 74.0(50.1-91.3) vs. 84.6(63.4-100.7), BSI 4(2-8) vs. 3(1-6). Paed-BE had a higher risk of exacerbations when adjusted for age, sex, <italic>Pseudomonas</italic> infection, %FEV<sub>1</sub>, Inhaled antibiotic use, macrolide use, asthma and smoking: HR 1.59(1.30-1.94). <bold>Conclusions:</bold> despite younger age, patients with paed-BE have worse outcomes than adult- BE. This may be attributed to different aetiologies or to longer disease duration.
Authors
- Francesco Blasi (ORCID: https://orcid.org/0000-0002-2285-9970)
- Josje Altenburg (ORCID: https://orcid.org/0000-0002-7248-963X)
- Michal Shteinberg (ORCID: https://orcid.org/0000-0002-0432-3398)
- Pieter Goemmine
- Charles Haworth (ORCID: https://orcid.org/0000-0001-7126-2874)
- J.S. Elborn (ORCID: https://orcid.org/0000-0002-2323-442X)
- Felix C. Ringshausen (ORCID: https://orcid.org/0000-0001-9084-4968)
- Eva Polverino (ORCID: https://orcid.org/0000-0002-4058-5109)
- Katerina Dimakou (ORCID: https://orcid.org/0000-0001-7457-4611)
- Rosario Menéndez (ORCID: https://orcid.org/0000-0002-3592-3839)
- James Duncan Chalmers (ORCID: https://orcid.org/0000-0001-5514-7868)
- Montserrat Vendrell (ORCID: https://orcid.org/0000-0002-6879-5757)
- Anthony De Soyza (ORCID: https://orcid.org/0000-0002-8566-0344)
- Pierre‐Régis Burgel (ORCID: https://orcid.org/0000-0003-0903-9828)
- Stefano Aliberti (ORCID: https://orcid.org/0000-0002-0090-4531)
- Antoní Torres (ORCID: https://orcid.org/0000-0002-8643-2167)
- Megan Crichton (ORCID: https://orcid.org/0009-0008-9277-6573)
- Marlène Murris (ORCID: https://orcid.org/0000-0003-2881-2740)
- Adam Hill
- Michael Loebingher
- Wim Borsma
Institutions
- Queen's University Belfast (GB)
- Humanitas University (IT)
- Inserm (FR)
- Université Paris Cité (FR)
- Royal Papworth Hospital (GB)
- Ninewells Hospital (GB)
- Harefield Hospital (GB)
- Edinburgh Royal Infirmary (GB)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Medizinische Hochschule Hannover (DE)
- Assistance Publique – Hôpitaux de Paris (FR)
- Northwest Hospital (US)
- Institut d'Investigació Biomèdica de Girona (ES)
- Hospital Clínic de Barcelona (ES)
- Rappaport Family Institute for Research in the Medical Sciences (IL)
- Vall d'Hebron Hospital Universitari (ES)
- NIHR Newcastle Biomedical Research Centre (GB)
- Institut Cochin (FR)
- Hospital Universitari de Girona Doctor Josep Trueta (ES)
- IRCCS Humanitas Research Hospital (IT)
- AZ Sint-Lucas (BE)
- Instituto de Investigación Sanitaria La Fe (ES)
- Sotiria General Hospital (GR)
- Universitat de Barcelona (ES)
- University of Amsterdam (NL)
Publication Details
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa2391
- Citations
- 1
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.42